Laboratory evaluation of hypercoagulability with venous or arterial thrombosis - Venous thromboembolism, myocardial infarction, stroke, and other conditions

被引:0
作者
Van Cott, EM
Laposata, M
Prins, MH
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Univ Maasticht, Dept Clin Epidemiol, Maastricht, Netherlands
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective.-To provide recommendations for hypercoagulation testing for patients with venous, arterial, or neurovascular thrombosis, as reflected in the medical literature and the consensus opinion of recognized experts in the field. Data Sources, Extraction, and Synthesis.-The authors extensively examined the literature and current practices, and prepared a draft manuscript with preliminary recommendations. The draft manuscript was circulated to each of the expert participants (n = 30) in the consensus conference prior to the convening of the conference. The manuscript and recommendations were then presented at the conference for discussion. Recommendations were accepted if a consensus of the 28 experts attending the conference was reached. The discussions were also used to revise the manuscript into its final form. Conclusions.-The resulting article provides 17 recommendations for hypercoagulation testing in the setting of venous, arterial, or neurovascular thrombosis. The supporting evidence for test selection is analyzed and cited, and consensus recommendations for test selection are presented. Issues for which a consensus was not reached at the conference are also discussed.
引用
收藏
页码:1281 / 1295
页数:15
相关论文
共 229 条
[41]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[42]   PREVENTION OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY BY REDUCING LIPOPROTEIN (A) LEVELS WITH LOW-DENSITY-LIPOPROTEIN APHERESIS [J].
DAIDA, H ;
LEE, YJ ;
YOKOI, H ;
KANOH, T ;
ISHIWATA, S ;
KATO, K ;
NISHIKAWA, H ;
TAKATSU, F ;
KATO, H ;
KUTSUMI, Y ;
YAMADA, N ;
NOMA, A ;
YAMAGUCHI, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (15) :1037-1040
[43]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[44]  
de Godoy JMP, 2000, ANGIOLOGY, V51, P473
[45]   Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients [J].
De Stefano, V ;
Chiusolo, P ;
Paciaroni, K ;
Casorelli, I ;
Rossi, E ;
Molinari, F ;
Servidei, S ;
Tonali, PA ;
Leone, G .
BLOOD, 1998, 91 (10) :3562-3565
[46]   Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction [J].
de Winter, RJ ;
Bholasingh, R ;
Lijmer, JG ;
Koster, RW ;
Gorgels, JPMC ;
Schouten, Y ;
Hoek, FJ ;
Sanders, GT .
CARDIOVASCULAR RESEARCH, 1999, 42 (01) :240-245
[47]   THROMBOSIS IN ANTITHROMBIN-III-DEFICIENT PERSONS - REPORT OF A LARGE KINDRED AND LITERATURE-REVIEW [J].
DEMERS, C ;
GINSBERG, JS ;
HIRSH, J ;
HENDERSON, P ;
BLAJCHMAN, MA .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (09) :754-761
[48]   IS HYPERHOMOCYSTEINAEMIA A RISK FACTOR FOR RECURRENT VENOUS THROMBOSIS [J].
DENHEIJER, M ;
BLOM, HJ ;
GERRITS, WBJ ;
ROSENDAAL, FR ;
HAAK, HL ;
WIJERMANS, PW ;
BOS, GMJ .
LANCET, 1995, 345 (8954) :882-885
[49]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[50]  
DESTEFANO V, 1994, THROMB HAEMOSTASIS, V72, P352